Mesangial cells in glomeruli are located under a fenestrated capillary endothelium and are exposed to hydrostatic pressure necessary to sustain normal filtration (1-3). Progressive renal diseases, such as diabetic nephropathy, remnant kidney, and hypertensive nephropathy, lead to prolonged glomerular hypertension, which is involved in the mesangial cell proliferation that is considered to be the most important factor mediating glomerular sclerosis (4 -11). However, the mechanism of these changes under glomerular hypertension remains largely unknown. Hishikawa et al. (12) have reported that, in vascular smooth muscle cells, pressure promotes DNA synthesis and cell growth probably via protein kinase C (PKC), 1 although the detailed mechanism between pressure as an extracellular stimulus and proliferation is unknown.
Mesangial cells in glomeruli are located under a fenestrated capillary endothelium and are exposed to hydrostatic pressure necessary to sustain normal filtration (1) (2) (3) . Progressive renal diseases, such as diabetic nephropathy, remnant kidney, and hypertensive nephropathy, lead to prolonged glomerular hypertension, which is involved in the mesangial cell proliferation that is considered to be the most important factor mediating glomerular sclerosis (4 -11) . However, the mechanism of these changes under glomerular hypertension remains largely unknown. Hishikawa et al. (12) have reported that, in vascular smooth muscle cells, pressure promotes DNA synthesis and cell growth probably via protein kinase C (PKC), 1 although the detailed mechanism between pressure as an extracellular stimulus and proliferation is unknown.
Various growth factors and mitogenic stimuli are known to induce the activation of mitogen-activated protein kinase (MAPK), a serine/threonine kinase (13, 14) . This kinase activity is up-regulated through phosphorylation on tyrosine and threonine residues by MAPK/extracellular signal-regulated kinase kinases (MEKs) (15, 16) . MEKs are substrates for Raf-1 (17, 18) , which has been reported to be activated either through receptors involved in Ras or a PKC-dependent pathway (19, 20) . These MAPK activators cause the translocation of MAPK from the cytosol to the nucleus (21) (22) (23) , where transcription factors such as Elk-1 (24) and c-Ets (25, 26) are substrates for MAPK. This indicates that MAPK serves as an important regulator of transcriptional activity related to proliferation. Recently, Lavoie et al. (27) reported that cyclin D1 expression, which is one of the earliest cell cycle-related events to occur during the G 0 /G 1 to S phase transition, is regulated positively by MAPK. Therefore, increasing interest has been paid to the role of MAPK in the cell cycle (28 -30) . We recently showed that pressure enhances G 1 /S progression and promotes the rate of DNA synthesis in mesangial cells (31) . However, MAPK activation and its physiological effects in glomerular hypertension are presently unknown. We investigated MAPK activation and cell proliferation in mesangial cells using a pressure-loading apparatus. We show here that applied pressure is a novel activator of MAPK. Furthermore, we demonstrate that MAPK activation plays a role in pressure-induced proliferation, probably via cyclin D1 expression.
EXPERIMENTAL PROCEDURES
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¶ To whom correspondence should be addressed. Tel.:81-836-22-2234; Fax: 81-836-22-2232/22-2246; E-mail: mizukami@po.cc.yamaguchi-u. ac.jp. inhibitor) were bought from New England Biolabs (Beverly, MA). Antiphospho-JNK1 antibody (Thr-183 and Tyr-185), anti-JNK1 antibody, anti-MAPK antibody, anti-c-Fos antibody, anti-cyclin D1 antibody, peptide substrate of myelin basic protein (APRTPGGRR), and protein A/Gagarose were from Santa Cruz Biotechnology (Santa Cruz, CA). Antic-Jun antibody and anti-phospho-tyrosine antibody were from Transduction Laboratories (Lexington, KY). Anti-rabbit and anti-mouse immunoglobulin G antibodies coupled to peroxidase were obtained from Promega (Madison, WI). Anti-rabbit immunoglobulin G antibody-linked fluorescein isothiocyanate was from Amersham International plc (Buckinghamshire, UK). The enhanced chemiluminescence reaction assay kit and PKC assay kit were from Pierce. Cell growth was estimated with a cell counting kit (Dojindo Laboratories, Kumamoto, Japan), which is a modified MTT assay kit using WST-1. Genistein, chelerythrine, and GF109203X were from Calbiochem-Novabiochem International (San Diego, CA). All other chemicals were commercially available.
Preparation of Cells-Rat mesangial cells were isolated as described previously (31, 32) . Mesangial cells were plated at a density of 5 ϫ 10 5 cells/dish in 100-mm culture dishes. After incubation in serum-free RPMI 1640 medium for 72 h, the cells were placed for the indicated times under high pressure conditions at 37°C. High pressure conditions were applied using a pressure-loading apparatus allowing for several levels of air pressure under constant O 2 and CO 2 concentration and temperature as described previously (31) . For each time period, cells were collected with a rubber policeman and used for biochemical analyses.
Electrophoresis and Immunoblotting-The collected cells were lysed with lysis buffer (1% Triton X-100, 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerol phosphate, 1 mM sodium orthovanadate, leupeptin (1 g/ml), 1 mM phenylmethanesulfonyl fluoride). The cellular extracts and molecular mass standards were electrophoresed in 12.5% (w/v) polyacrylamide gels in the presence of SDS and transferred to polyvinylidene difluoride membranes (0.45 m, Millipore, Bedford, MA) in the case of phospho-MAPK and phospho-Elk-1, or nitrocellulose membranes for other proteins. The blots were blocked with 5% non-fat dry milk in Tris-buffered saline containing 0.05% (w/v) Tween 20, and incubated with antibody. After the blots were washed, the antigens were visualized by enhanced chemiluminescent detection reagents. The levels of MAPK phosphorylation were determined from the immunoblots by densitometric analysis and were corrected for amounts of MAPK protein.
MAPK Activity and PKC Activity Assay-MAPK activity was determined as described previously (23) . Briefly, the cells were lysed in lysis buffer and clarified by centrifugation at 15,000 ϫ g for 10 min at 4°C. Protein content was normalized, and the lysates were incubated with anti-phospho-MAPK antibody followed by protein A/G-agarose. The complexes were washed twice in lysis buffer and twice in kinase buffer (25 mM Tris (pH 7.5), 5 mM ␤-glycerol phosphate, 2 mM dithiothreitol, 0.1 mM sodium orthovanadate, 10 mM MgCl 2 ). Kinase reactions were carried out by resuspending the complexes in 50 l of kinase buffer containing 100 M ATP and 1 g of Elk-1, and incubating for 30 min at 30°C. The reaction products were electrophoresed in SDS-polyacrylamide (12.5%) gels, transferred to polyvinylidene difluoride membranes, and probed with anti-phospho-Elk-1 antibody. As another method, after cell lysates were incubated with anti-MAPK antibody, MAPK activity was measured by incubating cell extracts for 10 min at 30°C with 1 mM peptide substrate containing the sequence of myelin basic protein phosphorylated by MAPK (APRTPGGRR) in buffer (25 mM Tris-HCl, pH 7.4, 10 mM MgCl 2 , 1 mM dithiothreitol, 40 M ATP, 2 Ci of [␥-32 P]ATP, 2 mM protein kinase inhibitor peptide, 0.5 mM EGTA). The reaction was stopped by the addition of 0.6% HCl, 1 mM ATP, and 1% bovine serum albumin, and the mixture was centrifuged at 3000 ϫ g for 5 min. The supernatant was spotted onto 1.0 ϫ 1.0-cm squares of P81 paper (Whatman), which was washed five times for 10 min each time with 0.5% phosphoric acid, rinsed once with ethanol, dried, and counted by the Cerenkov technique (33) . PKC activity was measured with a colorimetric PKC assay kit (Pierce) according to the manufacturer's instructions.
Immunofluorescent Staining of Phospho-MAPK-Mesangial cells were seeded in a Chamber Slide (Lab-Tek, Nunc Inc., Naperville, IL) at a density of 3 ϫ 10 4 cells/well. The cells were subjected to 70 mm Hg high pressure for 10 min and then fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min at 4°C. Following fixation, the cells were permeabilized with 0.2% Triton X-100 in PBS for 15 min and blocked with 10% fetal calf serum (FCS) in PBS for 30 min. The cells were then incubated for 1 h at room temperature with antibody against phospho-MAPK at 1:100 dilution in PBS containing 0.1% sheep serum albumin, washed with PBS, and incubated for an additional hour at room temperature with fluorescein isothiocyanate-conjugated antirabbit immunoglobulin G antibody at 1:100 dilution in PBS. The cells were viewed with a fluorescence microscope (Axioplan 2, Carl Zeiss Co., Heidelberg, Germany).
Transfection of Antisense MAPK into Mesangial Cells-Oligonucleotide transfection was determined as described previously (34) . Briefly, the phosphorothioate oligonucleotide with the sequence 5Ј-GCC GCC GCC GCC GCC AT-3Ј was synthesized as an antisense DNA. Control phosphorothioate oligonucleotides were synthesized with the following sequences: 5Ј-ATG GCG GCG GCG GCG GC-3Ј (sense) and 5Ј-CGC GCG CTC GCG CAC CC-3Ј (scrambled). The cells (typically 80% confluent in 24-well dishes) were washed three times with PBS. Appropriate dilutions of oligonucleotides in 200 l of serum-free RPMI 1640 including liposomes (Tfx-50, Promega Co.) were preincubated at room temperature for 15 min. The cells were incubated for 2 h at 37°C in the presence of 5% CO 2 . At the end of the incubation period, 1 ml of medium containing 10% FCS was added. After incubating for 48 h, the cells were reseeded in 96-well dishes, and incubated with serum-free medium for 24 h after washing with 500 l of PBS. After a further 24 h the medium was replaced with medium containing 0.5% FCS. After incubation under high pressure conditions, cell number was estimated by WST-1 assay. The densitometric measurements were done with plate analyzer (ETY3A, Toyo Sokki Co., Kanagawa, Japan).
DNA Synthesis-DNA synthesis was estimated with an immunocytochemical assay kit using monoclonal anti-bromodeoxyuridine (BrdUrd) antibody to detect BrdUrd incorporation into cellular DNA (RPN 20, Amersham International). Briefly, growing cells were seeded in chamber slides at a density of 3 ϫ were prepared from mesangial cells exposed to 70 mm Hg high pressure for the indicated times and subjected to immunoblotting with anti-phospho-MAPK antibody (A) or anti-MAPK antibody (B). A representative immunoblot from three independent experiments is shown. The levels of MAPK phosphorylation were determined from the immunoblots by densitometric analysis (mean Ϯ S.E., n ϭ 3) (C) as described under "Experimental Procedures." for 30 min, BrdUrd incorporation was visualized with 3,3Ј-diaminobenzidine tetrahydrochloride as a substrate according to the manufacturer's instructions. BrdUrd-positive cells and total cells (200 -300 cells) in 10 fields that were selected randomly in each sample were counted, and the proportion of positive cells to total cells was calculated.
RESULTS

MAPK Activation by High Pressure-MAPK is activated
through the phosphorylation of Thr-202 and Tyr-204 by MEK (13, (35) (36) (37) . We initially examined the phosphorylation of MAPK in mesangial cells under high pressure conditions by immunoblotting with an antibody that recognizes phosphorylation at Tyr-204 in MAPK. In pressure-treated cells, their level of MAPK phosphorylation was significantly increased at 1 min after pressure-load as compared with untreated cells (Fig. 1, A  and C) . The amount of MAPK remained almost constant throughout pressure-load (Fig. 1B) . To confirm MAPK activation by high pressure, we examined MAPK activity by an immunoprecipitation kinase assay using Elk-1 as a substrate. MAPK activity rose rapidly after pressure-load with almost the same kinetics as MAPK phosphorylation (Fig. 2, A and B) . To further confirm MAPK activation by high pressure, we carried out another kinase assay using myelin basic protein as described under "Experimental Procedures." MAPK activity with MAPK immunoprecipitates and myelin basic protein peptide, significantly increased (6-fold) with similar kinetics to MAPK phosphorylation and MAPK activity using Elk-1 as a substrate (data not shown). When mesangial cells were exposed to high pressure (30, 50, 70 , or 90 mm Hg) or to atmospheric pressure (0 mm Hg), the level of MAPK phosphorylation increased in a pressure-dependent manner (Fig. 3, A and C) . The amount of MAPK remained almost constant in each lane (Fig. 3B) . These findings show that MAPK is activated by tyrosine phosphorylation in mesangial cells under high pressure conditions. It is known that JNK1, a member of the MAPK superfamily, is activated by phosphorylation by SEK1 in response to various stresses (38 -41) . We measured the level of JNK1 phosphorylation necessary for activation by immunoblotting with an antiphospho-JNK1 antibody. As shown in Fig. 4A , JNK1 was already phosphorylated under the control conditions, and the level of phosphorylation was rather lower during pressureload, although the amount of JNK1 remained almost unchanged during pressure-load (Fig. 4B) . These results indicate that JNK1 phosphorylation decreases during pressure-load.
To investigate upstream kinases in the pressure-induced 
FIG. 2. MAPK activity in rat mesangial cells under high pressure conditions.
Cell extracts (600 g of protein) were prepared from mesangial cells exposed to 70 mm Hg high pressure for the indicated times and subjected to immunoprecipitation with anti-phospho-MAPK antibody followed by protein A/G-agarose. The complexes were incubated with 100 M ATP and 1.0 g of Elk-1, and subjected to immunoblotting with anti-phospho-Elk-1 antibody (A). A representative immunoblot from three independent experiments is shown. The MAPK activities were determined from the immunoblots by densitometric analysis (mean Ϯ S.E., n ϭ 3) (B).
MAPK activation, we examined the MAPK phosphorylation in the presence of inhibitors for PKC and tyrosine kinases. Genistein, a tyrosine kinase inhibitor, inhibited pressure-induced MAPK phosphorylation in a dose-dependent manner (Fig. 5, A  and C) . However, chelerythrine and GF109203X, PKC inhibitors, did not affect MAPK phosphorylation (Fig. 5, A and C) . The amount of MAPK was almost constant in each lane (Fig.  5B) . Furthermore, to confirm the effect of genistein, we examined tyrosine phosphorylation with immunoblotting using antiphospho-tyrosine antibody. Applied pressure induces the tyrosine phosphorylation of proteins with molecular masses of 35, 53, and 180 kDa, and the tyrosine phosphorylation was inhibited by genistein (Fig. 5D ) in a dose-dependent manner (0.1-10 M). PKC inhibitors had no effects on the pressure-induced tyrosine phosphorylation (Fig. 5D) . Genistein also inhibited pressure-induced cell proliferation, whereas PKC inhibitors had no effect (data not shown). PKC activity was weakly increased by applied pressure, the activity of which was blocked by PKC inhibitors, but not by 10 M genistein (data not shown). These findings suggest that tyrosine kinases are involved in the pressure-induced MAPK activation.
MAPK substrates are present in various subcellular fractions (21, 22) . To examine the physiological effect of MAPK under high pressure conditions, we observed the subcellular localization of MAPK by immunocytochemical staining using an anti-phospho-MAPK antibody. Immunocytochemical observations showed the phosphorylated MAPK to be present mainly in the cytoplasm 1 min after pressure-load (data not shown), and the nuclear staining was significantly increased after 10 min of pressure-load (Fig. 6, C and D) . The staining was not observed under control conditions (atmospheric pressure) (Fig. 6, A and B) and was inhibited by preincubating the primary antibody with activated MAPK (data not shown). These findings suggest that MAPK has a physiological effect on the nucleus.
It is known that MAPK in the nucleus can phosphorylate Elk-1 (24), a transcription factor, and that this phosphorylation subsequently leads to an increase in the expression of c-Fos (42) . We examined the expression of c-Fos under high pressure conditions by immunoblotting and found it to be significantly increased for 12 h after pressure-load (Fig. 7, A and B) . This increase was inhibited by treatment with 50 M MEK inhibitor (Fig. 8, A and B) . In addition, antisense DNA against MAPK, as described below, also inhibits pressure-induced c-Fos expression (data not shown). On the other hand, the expression of c-Jun, a nuclear transcription factor that is induced by JNK activation, remained almost unchanged under 70 mm Hg pressure for up to 48 h (Fig. 9 ). These observations demonstrate that applied pressure induces the expression of c-Fos via the activation of MAPK.
Cell Proliferation through MAPK Activation by High Pressure-We recently showed that high pressure enhances the rates of DNA synthesis and cell proliferation (31) . To investigate the role of MAPK in pressure-induced proliferation, we transfected an antisense oligonucleotide against MAPK into mesangial cells, and found MAPK expression to be inhibited in a concentration-dependent manner (0.1-2.0 M) (Fig. 10, A and  B) . Incubation of cells with 2 M sense or scrambled DNA for MAPK did not significantly affect MAPK expression for up to 4 days. JNK1 expression remained almost unchanged in cells transfected with each MAPK DNA as compared with untreated cells. We examined cell proliferation using the WST-1 assay. Mesangial cells whose MAPK protein was depleted by antisense DNA, completely inhibited pressure-induced proliferation, but sense DNA or scrambled DNA-treated cells enhanced proliferation to the same extent as untreated cells for up to 48 h under high pressure conditions (Fig. 11 ). Cell treatment with MEK inhibitor produced similar results in terms of cell numbers (data not shown). DNA synthesis in mesangial cells was enhanced under 70 mm Hg high pressure condition as described previously (31) . This enhancement was strongly blocked by 50 M MEK inhibitor (Fig. 12) . These findings show that MAPK activation participates in pressure-induced proliferation. In addition, the applied pressure for 30 min weakly induced the cell proliferation at 24 h under the condition of atmospheric pressure, but not at 48 h (data not shown), which suggests that transient pressure can proliferate mesangial cells.
It was recently reported that cyclin D1 expression, which is required to pass the G 1 restriction point, is positively regulated by MAPK (27) . We examined cyclin D1 expression under high pressure conditions by immunoblotting using an anti-cyclin D1 antibody. The expression of cyclin D1 was induced after 12 h of pressure-load (Fig. 13, A and B) , and the expression was significantly suppressed to basal levels by MEK inhibitor (Fig. 14,  A and B) . The results suggest that cyclin D1, induced by MAPK activation, may be involved in cell proliferation under high pressure conditions. DISCUSSION We have investigated MAPK activation in mesangial cells exposed to high pressure. During the study we demonstrated that a few minutes of pressure-load induces the activation and nuclear translocation of MAPK, which leads to an increase in the expression of c-Fos during the pressure-load. MAPK activation under high pressure conditions increases cyclin D1 expression and DNA synthesis, and finally enhances cell cycle progression. In addition, pressure-induced MAPK activation and cell proliferation might be involved in tyrosine kinases.
MAPK is strongly activated by growth factors and growthpromoting hormones (13, (43) (44) (45) (46) (47) , in contrast to JNK, which is preferentially activated by environmental stresses and proinflammatory cytokines (14, 38, 48, 49) . In this study, applied pressure, which is a physical force generated by hydrostatic pressure, promoted the activation of MAPK but not JNK1. MAPK has been reported to phosphorylate Elk-1, a nuclear transcription factor (50, 51) . Elk-1 binds to a serum response element within the c-fos promoter region together with a serum response factor, inducing c-Fos expression (42, 52, 53) . High pressure induces c-Fos expression, and the induction is inhibited by both MAPK antisense oligonucleotide and MEK inhibitor. These observations demonstrate that MAPK activation is involved in the expression of c-Fos under high pressure conditions. A transcription factor, c-Ets, is also a substrate for MAPK (54, 55) . The promoter region of cyclin D1 has an Etslike binding domain that regulates cyclin D1 expression (25, (27) reported that MAPK plays a positive regulatory role in cyclin D1 expression. Consistent with their report, our present data show that pressure-load activates MAPK, which increases cyclin D1 expression and an enhancement of DNA synthesis and cell growth. Cyclin D1 plays an important role in the entry of cells into S phase and cell cycle progression (56 -59) . Therefore, cyclin D1 expression may participate in pressure-induced proliferation since pressure-load contributes to cell cycling by enhancing G 1 /S progression and promoting the rate of DNA synthesis in mesangial cells as described previously (31) .
The mechanism of MAPK activation under high pressure conditions is poorly elucidated. It does not appear that mesangial cells secrete growth factors that would activate MAPK during pressure-load for the following two reasons. First, we added a supernatant from pressure-treated cells to untreated cells and observed no cell proliferation under the experimental conditions employed (data not shown). This result is consistent with studies on smooth muscle cells as described previously (12) . Second, MAPK is rapidly activated, reaching a peak at 1 min after pressure-load; there seems to be no time delay due to the secretion of growth factors after pressure-load. Hishikawa et al. (12) have reported that pressure promotes the activation of PKC with Ca 2ϩ mobilization in cultured smooth muscle cells. It is well known that various stresses activate distinct PKC isoforms (60 -63) . In mesangial cells as well as smooth muscle cells, it is possible that pressure-load activates PKC isoforms. In our study, PKC activity was weakly increased by applied pressure. However, pressure-induced MAPK phosphorylation was inhibited by tyrosine kinase inhibitor, but not by PKC inhibitors. In addition, applied pressure induces tyrosine phosphorylation of proteins with molecular masses of 180, 53, and 35 kDa, and tyrosine phosphorylation was inhibited by genistein. Thus, it is strongly suggested that tyrosine kinases are involved in the pressure-induced MAPK activation.
MAPK activation in mesangial cells is thought to play an important role in the development of renal injury. Pressureload itself activates MAPK, which contributes to the mesangial cell proliferation that is a central feature of numerous glomerular diseases (8 -11) . In addition, Bokemeyer et al. (64) have recently reported that MAPK is significantly activated by proliferative glomerulonephritis in response to immune injury. The proliferation induced by renal diseases is an important aspect of the pathogenic process of glomerular sclerosis (64) . In these diseases, this is often accompanied not only by the proliferation of mesangial cells but also by expansion of the extra- Cell numbers under the conditions of 0 mm Hg (atmospheric pressure) or 70 mm Hg (high pressure) for the indicated times were determined by WST-1 assay (mean Ϯ S.E., n ϭ 4, *p Ͻ 0.05) as described under "Experimental Procedures." cellular matrix (65) (66) (67) (68) . Transforming growth factor-␤ (TGF-␤) is reported to be a factor in regulating the extracellular matrix and inducing glomerular sclerosis (67) (68) (69) . It is known that the promoter region of TGF-␤ contains an AP1 element (70 -73) and that c-Fos expression regulates TGF-␤ expression. In our study, we found that pressure-load significantly increases the expression of TGF-␤ in mesangial cells for 24 h. 2 Pressure-load may increase TGF-␤ expression through c-Fos induced by MAPK activation. It is possible that pressure-load contributes to the development of renal injury by both mesangial proliferation and matrix expansion through MAPK activation. This MAPK activation of mesangial cells in response to pressure-load might be an underlying mechanism in the development of renal injury with glomerular hypertension. The present study provides new insights into the role of MAPK in glomerular hypertension. were prepared from mesangial cells exposed to 0 mm Hg (atmospheric pressure) or 70 mm Hg (high pressure) for the indicated times and subjected to immunoblotting with anti-cyclin D1 antibody (A). A representative immunoblot from three independent experiments is shown. The amount of cyclin D1 was determined from the immunoblots by densitometric analysis (mean Ϯ S.E., n ϭ 3, *p Ͻ 0.05) (B).
FIG. 14. Effect of MEK inhibitor on cyclin D1 expression in mesangial cells under high pressure conditions. Cell extracts (40 g of protein) were prepared from the mesangial cells exposed to 0 mm Hg (atmospheric pressure) or 70 mm Hg (high pressure) for 24 h in the presence or absence of MEK inhibitor (50 M; PD98059), and subjected to immunoblotting with anti-cyclin D1 antibody (A). A representative immunoblot from three independent experiments is shown. The amount of cyclin D1 was determined from the immunoblots by densitometric analysis (mean Ϯ S.E., n ϭ 3, *p Ͻ 0.05) (B).
